Trump Announces 100% Tariffs on Pharma Imports

Pro-Trump narrative

America's dangerous dependence on foreign drug suppliers threatens national security and patient safety. China controls 90% of active pharmaceutical ingredients, while India produces half of the country's generics, with 54% higher severe adverse event rates than domestic drugs. Tariffs will rebuild secure domestic production without raising patient costs since middlemen absorb the increases.